Clinical Trials Logo

Esophageal Adenocarcinomas clinical trials

View clinical trials related to Esophageal Adenocarcinomas.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04171141 Terminated - Clinical trials for Gastrointestinal Tumors

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Start date: November 19, 2019
Phase: Phase 1
Study type: Interventional

A phase 1, open-label, dose escalation and expansion study of PF-07062119 in patients with selected advanced or metastatic gastrointestinal tumors

NCT ID: NCT00216008 Terminated - Clinical trials for Adenocarcinomas of the Gastroesophageal Junction

Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.

Start date: July 2005
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to find out the effectiveness of the experimental combination of Docetaxel, Cisplatin, and radiation therapy administered prior to the surgical removal of your esophageal cancer.